Inhibitors of Farnesyltransferase and Geranylgeranyltransferase-I for Antitumor Therapy: Substrate-Based Design, Conformational Constraint and Biological Activity

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|3|10|1075-1093

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.3, Iss.10, 2003-01, pp. : 1075-1093

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues

By Sebti S.M.   Hamilton A.D.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2767-2782

Informa Healthcare

Access to resources Recommend Favorite

Non-peptidic, Non-prenylic Bisubstrate Farnesyltransferase Inhibitors, 4. Effect on Farnesyltransferase Inhibitory Activity of Conformational Restrictions in the Central Group

By Schlitzer M.   Sattler I.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 3, 2000-03 ,pp. : 117-124

Pharmaceutical Press

Access to resources Recommend Favorite

Structure Based Design of Benzophenone-Based Non-Thiol Farnesyltransferase Inhibitors

By  

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1713-1722

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Angiogenesis in Cancer Therapy – Synthesis and Biological Activity

By  

Current Medicinal Chemistry, Vol. 22, Iss. 33, 2015-11 ,pp. : 3830-18

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesyltransferase Inhibitors: A Detailed Chemical View on an Elusive Biological Problem

By  

Current Medicinal Chemistry, Vol. 15, Iss. 15, 2008-06 ,pp. : 1478-1492

Bentham Science Publishers

Access to resources Recommend Favorite